Author:
Asma Gati,Amal Gorrab,Raja Marrakchi,Amine Derouiche,Mohammed Chebil,Amel Ben Ammar Elgaaied
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–57.
2. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798–805.
3. Logan JE, Rampersaud EN, Sonn GA, Chamie K, Belldegrun AS, Pantuck AJ, et al. Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol. 2012;14:65–78.
4. Escudier B. Emerging immunotherapies for renal cell carcinoma. Ann Oncol. 2012;23 Suppl 8:viii35–40.
5. Dannenmann SR, Hermanns T, Bransi A, Matter C, von Boehmer L, Stevanovic S, et al. Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin d1 in patients with clear cell renal cell carcinoma. Cancer Immunol Res. 2013;1:288–95.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献